Congenital Hearing Loss

All products featured here are independently selected by our editors and writers.If you buy something through links on our site, Mashable may earn an affiliate commission. Image: AncestryDNA® By Nicole Cammorata Mashable Shopping 2019-05-11 09:00:00 UTC AncestryDNA® is having a huge sale for Mother's Day this year, saving you $40 off one of their testing kits. (Got two moms? Looking for an early Father's Day gift? Buy two AncestryDNA® kits and get free shipping.) At-home DNA and ancestry testing kits are *the* hot gift item this year, and if your mom isn't already one of the 26 million people spitting into a tube in the name of science, then now is the time. (Read our guide to what each testing kit does here.) An AncestryDNA® kit will provide your mom with a pie chart that breaks down the percentages of her ethnographic make-up, maps showcasing migration patterns, and info about the regions from which her ancestors hailed — sometimes down to the ci...

Here's all the best sales happening for Mother's Day this weekend.   (Photo: Fitbit / Homesick / Hello Fresh) — Recommendations are independently chosen by Reviewed's editors. Purchases you make through our links may earn us a commission. Mother's Day is practically here (it falls on  Sunday, May 10) ,   and, like any major holiday, its arrival comes along with a ton of sales. In the spirit of celebrating mom, retailers are offering up a slew of standout deals and discounts that will be running all weekend long, and to help you shop smartly, we're rounding up the best of the best. Need help finding products?  Sign up for our weekly deals newsletter. It's free and you can unsubscribe any time. With massive markdowns at Nordstrom, Kohl's and more, we've compiled a full list of the stores blessing us with with the most fabulous promotions and can't-miss discounts you (and mom!) will be able to score. Read ahead for savings galore. 1. Koh...

Learn more about your heritage and save while doing so.   (Photo: AncestryDNA) — Recommendations are independently chosen by Reviewed's editors. Purchases you make through our links may earn us a commission. Looking for a way to feel closer to your family while in isolation? Just in time for Mother's Day, AncestryDNA is allowing you to discover all kinds of fascinating things you never knew about your ethnic roots and family tree with price slashes on two of its most popular kits. Need help finding products?: Sign up for our weekly newsletter. It's free and you can unsubscribe at any time. From today through Sunday, May 10 , you can get a standard AncestryDNA test for $59 instead of its usual $99 for a savings of $40. Additionally, you can get the AncestryHealth kit, which is essentially the same as the standard kit with added insights into your health, for just $99. This is a $50 discount from its typical $149 price tag (note: AncestryHealth is not available...

Nota bene: If you buy through the links in this article, InsideHook may earn a small share of the profits. It's a good time to build — or is that rebuild? — your family tree. Helping you and your fam connect with the past: AncestryDNA kits, now on sale for Mother's Day. Ancestry is the best-selling consumer DNA kit in the world, and part of the world's largest consumer DNA network. It can trace your roots back to over 1000 different global regions, discover migration paths and present the info with an interactive timeline, geographic details about your history and a pie chart fully detailing your ethnicity. And all you need to give is a saliva sample. Send your spit kit back, and you'll know more than you ever wanted to about your genealogy about 6-8 weeks later. Once you're an Ancestry member, you can also view photos and stories from your family's past via the National Archives records. By the way, if you're worried about sending saliva sam...

Avanir Pharmaceuticals has agreed to pay over $95 million to resolve kickback allegations as well as "false and misleading" marketing of the drug Nuedexta in long-term care (LTC) facilities in a bid to get providers to prescribe it off-label for patients with dementia, the US Department of Justice (DOJ) reports.   "Kickbacks have the power to corrupt a provider's medical judgment," Jody Hunt, assistant attorney of the DOJ's Civil Division, said in a news release. "And it is particularly concerning when a pharmaceutical company uses kickbacks to drive up sales in connection with a vulnerable population, such as elderly patients in nursing care facilities." Nuedexta, a combination of dextromethorphan hydrobromide and quinidine sulfate, is approved by the US Food and Drug Administration (FDA) for the treatment of pseudobulbar affect (PBA), a condition characterized by involuntary, sudden, and frequent episodes of laughing or crying that occurs ...

Pseudobulbar affect (PBA) is a neurologic disorder that occurs due to neurological conditions or brain injury. Credit: NEUROtiker. Nuedexta is a combination drug comprised of dextromethorphan hydrobromide and quinidine sulphate. Credit: Shutterstock. Nuedexta is presumed to work by regulating excitatory neurotransmissions in the brain through sigma-1 receptor agonist activity and NMDA receptor antagonist activity. Credit: Nrets. Nuedexta (dextromethorphan hydrobromide / quinidine sulfate) is a combination drug indicated for the treatment of pseudobulbar affect (PBA). The drug was developed and manufactured by Avanir Pharmaceuticals. Avanir Pharmaceuticals received marketing authorisation for Nuedexta from the European Commission (EC) in June 2013, for the treatment of pseudobulbar affect (PBA). The company obtained the US Food and Drug Administration (FDA) approval for the drug for the treatment of PBA in October 2010. Nuedexta was launched in the US i...

Dextromethorphan-quinidine (Nuedexta), approved by the FDA for pseudobulbar affect based on studies in patients with amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS), appeared to be prescribed primarily for patients with other underlying disorders, an analysis of insurance records found. Few patients who received the drug had a diagnosis of MS (8.4%) or ALS (6.8%); most (57%) had a diagnosis of dementia or Parkinson's disease, reported Aaron Kesselheim, MD, JD, MPH, of Brigham and Women's Hospital in Boston, and co-authors in JAMA Internal Medicine. "Our study identified that this medication is primarily prescribed to patients with dementia or Parkinson's disease. This is concerning, since very few studies have evaluated the effectiveness or safety in this patient population," said lead author Michael Fralick, MD, of the University of Toronto. It is important physicians realize this medication was studied primarily in patients with ALS and MS...